Skip to main content
TipRanks
Go Ultimate75% OFF

Elaine Jones Insider Profile

4 Followers

Elaine Jones, Director at CytomX Therapeutics, holds 5.14K shares in CytomX Therapeutics (Ticker: CTMX), holds 27.50K shares in Gyre Therapeutics (Ticker: GYRE), holds ― shares in Gritstone bio (Ticker: GRTSQ). Most recently, Elaine Jones Bought ― shares of CytomX Therapeutics on Mar 31, 2023 for an estimated value of $7.75K.

Elaine Jones's Trading History

CTMX
CytomX Therapeutics
Mar 31, 2023DirectorInformative Buy7.75K$11.26K
NGNE
Neurogene
―Director―$0.00
~FLXN
Flexion Therapeutics
―――$0.00
NXTC
NextCure
―Director――
GRTSQ
Gritstone bio
――――
GYRE
Gyre Therapeutics
―Director―$130.90K

You May Also Like

Elaine Jones insider profile FAQ

What stocks does Elaine Jones hold?
Elaine Jones holds: CTMX, GYRE, GRTSQ, NXTC, ~FLXN, NGNE stocks.
What was Elaine Jones’s latest transaction?
Elaine Jones’s latest transaction was an Informative Buy of $7.75K.
What is Elaine Jones's role in CytomX Therapeutics?
Elaine Jones's role in CytomX Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.